Jean M. Engels, MS

Senior Director of Biostatistics
Tonix Pharmaceuticals, Inc.
Chatham, New Jersey

Jean M. Engels is Senior Director, Biostatistics at Tonix Pharmaceuticals, Inc. She received her MS from University of Washington and has 20 years of experience in the pharmaceutical industry. She has provided statistical support and oversight in phase I to III clinical trial design and analysis in multiple therapeutic areas including fibromyalgia, PTSD, acute and chronic migraine, tension headache, cystic fibrosis, depression, and cocaine intoxication.

Presentation(s):

• P-046 - (Poster #46) Randomized, double-blind, placebo-controlled confirmatory Phase 3 trial of bedtime sublingual cyclobenzaprine (TNX-102 SL) in fibromyalgia

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-036 - (Poster #36) Sublingual cyclobenzaprine (TNX-102 SL) for fibromyalgia: efficacy and safety in two randomized placebo-controlled trials

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-037 - (Poster #37) TNX-102 SL, cyclobenzaprine HCl sublingual tablets, demonstrates pain reduction and favorable tolerability in patients with fibromyalgia

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST